Evidence map›Paper›PMID 36826760›Full record

ReviewCancer metastasis reviews2023

Nanoparticle-mediated cancer cell therapy: basic science to clinical applications.

Jaya Verma, Caaisha Warsame, Rajkumar Kottayasamy Seenivasagam, Nirmal Kumar Katiyar, Eiman Aleem, Saurav Goel

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancer metastasis reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Self-illuminating liposome-derivedActa pharmaceutica Sinica. B · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Current Advances in Nanocarriers for Cancer Therapy.International journal of nanomedicine · 2025
    Review
  10. Review
  11. Article
  12. Recent Insights into Nanotechnology in Colorectal Cancer.Applied biochemistry and biotechnology · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jaya VermaSchool of Engineering, London South Bank University, London, SE10AA, UK.
Caaisha WarsameSchool of Engineering, London South Bank University, London, SE10AA, UK.
Rajkumar Kottayasamy SeenivasagamSurgical Oncology, PSGIMSR, Coimbatore, India.
Nirmal Kumar KatiyarSchool of Engineering, London South Bank University, London, SE10AA, UK.
Eiman AleemSchool of Applied Sciences, Division of Human Sciences, Cancer Biology and Therapy Research Group, London South Bank University, London, SE10AA, UK.
Saurav GoelSchool of Engineering, London South Bank University, London, SE10AA, UK. goels@lsbu.ac.uk.ORCID 0000-0002-8694-332X
London South Bank University · GBPSG Institute of Medical Sciences & Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Every sixth person in the world dies due to cancer, making it the second leading severe cause of death after cardiovascular diseases. According to WHO, cancer claimed nearly 10 million deaths in 2020. The most common types of cancers reported have been breast (lung, colon and rectum, prostate cases), skin (non-melanoma) and stomach. In addition to surgery, the most widely used traditional types of anti-cancer treatment are radio- and chemotherapy. However, these do not distinguish between normal and malignant cells. Additional treatment methods have evolved over time for early detection and targeted therapy of cancer. However, each method has its limitations and the associated treatment costs are quite high with adverse effects on the quality of life of patients. Use of individual atoms or a cluster of atoms (nanoparticles) can cause a paradigm shift by virtue of providing point of sight sensing and diagnosis of cancer. Nanoparticles (1-100 nm in size) are 1000 times smaller in size than the human cell and endowed with safer relocation capability to attack mechanically and chemically at a precise location which is one avenue that can be used to destroy cancer cells precisely. This review summarises the extant understanding and the work done in this area to pave the way for physicians to accelerate the use of hybrid mode of treatments by leveraging the use of various nanoparticles.

Indexed as

Cardiovascular DiseasesMelanomaNanoparticlesHumansMaleQuality of LifeCancerHEAsMD simulationsNanoparticles

Identifiers

PMID36826760
PMCPMC10584728
OpenAlexW4321749118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.